Source: Clinical and experimental immunology. Unidade: FM
Subjects: AUTOANTICORPOS, DIABETES MELLITUS INSULINO-DEPENDENTE (EPIDEMIOLOGIA;DIAGNÓSTICO), GLUTAMINA, CITOCINAS, PÂNCREAS (IMUNOLOGIA), DIABETES MELLITUS INSULINO-DEPENDENTE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GABBAY, M. Andrade Lima e DUARTE, A. J. S e SATO, M. N. Serum titres of anti-glutamic acid decarboxylase-65 and anti-IA-2 autoantibodies are associated with different immunoregulatory milieu in newly diagnosed type 1 diabetes patients. Clinical and experimental immunology, v. 168, n. 1, p. 60-67, 2011Tradução . . Disponível em: https://doi.org/10.1111/j.1365-2249.2011.04538.x. Acesso em: 22 ago. 2024.APA
Gabbay, M. A. L., Duarte, A. J. S., & Sato, M. N. (2011). Serum titres of anti-glutamic acid decarboxylase-65 and anti-IA-2 autoantibodies are associated with different immunoregulatory milieu in newly diagnosed type 1 diabetes patients. Clinical and experimental immunology, 168( 1), 60-67. doi:10.1111/j.1365-2249.2011.04538.xNLM
Gabbay MAL, Duarte AJS, Sato MN. Serum titres of anti-glutamic acid decarboxylase-65 and anti-IA-2 autoantibodies are associated with different immunoregulatory milieu in newly diagnosed type 1 diabetes patients [Internet]. Clinical and experimental immunology. 2011 ; 168( 1): 60-67.[citado 2024 ago. 22 ] Available from: https://doi.org/10.1111/j.1365-2249.2011.04538.xVancouver
Gabbay MAL, Duarte AJS, Sato MN. Serum titres of anti-glutamic acid decarboxylase-65 and anti-IA-2 autoantibodies are associated with different immunoregulatory milieu in newly diagnosed type 1 diabetes patients [Internet]. Clinical and experimental immunology. 2011 ; 168( 1): 60-67.[citado 2024 ago. 22 ] Available from: https://doi.org/10.1111/j.1365-2249.2011.04538.x